This website uses cookies to improve functionality and performance. We sometimes share information on how people use our site with third parties, including social media websites for advertising and marketing purposes. By continuing to browse the site or clicking “I accept cookies”, you agree to our use of cookies. You can manage or remove cookie settings and find further information by visiting our cookie information page.
Hi there, we see you're using OS, why not try our app?
Download
Skip to main content
1

Increase in demand for O D negative red cells. Updated guidance published by the National Blood Transfusion Committee

Letter of communication 18 July 2019

Useful links

The American Society for Apheresis (ASFA) http://www.apheresis.org/

ASFA is an organisation of physicians, scientists, and allied health professionals whose mission is to advance apheresis medicine for patients, donors and practitioners through education, evidence-based practice, research and advocacy. ASFA represents a broad range of professionals involved in: donor apheresis, apheresis in transplantation, and therapeutic apheresis.

Heart UK http://heartuk.org.uk

Heart UK are committed to raising awareness about the risks of high cholesterol, lobbying for better detection of those at risk and supporting health professional training. Their website provides information on cholesterol and LDL apheresis services in the UK.

European Group for Blood and Marrow Transplantation http://www.ebmt.org

The European Group for Blood and Marrow Transplantation promotes all aspects associated with the transplantation of haematopoietic stem cells from all donor sources and donor types including basic and clinical research, education, standardisation, quality control and accreditation for transplant procedures.

Sickle Cell Society http://www.sicklecellsociety.org

The Sickle Cell Society believes that individuals suffering from sickle cell disease have the right to quality care and aims to educate health carers and other professionals about the condition.